Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00837031
What this trial is testing

Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas

Who this might be right for
Metastatic Pancreatic Cancer
SCRI Development Innovations, LLC 72
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Early research (Phase 1)Looking for participantsNCT06010862
What this trial is testing

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerPancreas Cancer+4 more
Chongqing Precision Biotech Co., Ltd 36
Testing effectiveness (Phase 2)UnknownNCT02726854
What this trial is testing

Apatinib as Second-line Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 30
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07160283
What this trial is testing

The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer

Who this might be right for
Biliary Tract NeoplasmsPancreatic Neoplasms
The Second Affiliated Hospital of Shandong First Medical University 96
Testing effectiveness (Phase 2)Study completedNCT02358161
What this trial is testing

Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 78
Testing effectiveness (Phase 2)Temporarily pausedNCT00536770
What this trial is testing

Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Novacea 132
Testing effectiveness (Phase 2)UnknownNCT02455596
What this trial is testing

Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 20
Testing effectiveness (Phase 2)Looking for participantsNCT06584227
What this trial is testing

Adebrelimab and Chidamide for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
Liu Xiufeng 45
Not applicableStudy completedNCT04603586
What this trial is testing

Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses

Who this might be right for
Treatment
Changhai Hospital 119
Early research (Phase 1)Active Not RecruitingNCT05143970
What this trial is testing

First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors

Who this might be right for
Metastatic CancerMetastatic Breast CancerMetastatic Pancreatic Cancer+6 more
Institut Paoli-Calmettes 27
Early research (Phase 1)Study completedNCT02155088
What this trial is testing

BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 15
Early research (Phase 1)Study completedNCT01188785
What this trial is testing

Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic Cancer
Silenseed Ltd 15
Not applicableLooking for participantsNCT06698458
What this trial is testing

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic AdenocarcinomaMetastatic Pancreatic Cancer
Alpha Tau Medical LTD. 50
Early research (Phase 1)WithdrawnNCT02048943
What this trial is testing

Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer

Who this might be right for
Duct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+2 more
Roswell Park Cancer Institute
Early research (Phase 1)Looking for participantsNCT06596915
What this trial is testing

Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerPancreatic AdenocarcinomaBreast Cancer+1 more
Shandong Boan Biotechnology Co., Ltd 167
Testing effectiveness (Phase 2)Ended earlyNCT01834235
What this trial is testing

QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
Precision Biologics, Inc 81
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Not applicableEnded earlyNCT04106167
What this trial is testing

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Who this might be right for
Advanced Solid TumorLymphomaGastric Cancer+15 more
Fate Therapeutics 20
Next Page